Firenze, Italy
Events
ESCRS
8-12 September, 2023
Messe Wien Exhibition Congress Center, Vienna, Austria
Euretina
5-8 October, 2023
RAI Amsterdam, The Netherlands
AAO
3-6 November, 2023
Moscone Center, San Francisco, CA
News
BVI Announces Complete Enrollment of FINEVISION® HP IDE Clinical Study
WALTHAM, MA - May 1, 2023 (GLOBE NEWSWIRE) — BVI, a diversified global ophthalmic device company, today announced it has completed enrollment of its U.S. Investigational Device Exemption (IDE) clinical study for its latest hydrophobic trifocal intraocular lens, FINEVISION® HP. Read More
BVI Announces Certification for its Intraocular Lens Portfolio under the European Medical Device Regulation
WALTHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) — BVI, a diversified global ophthalmic device company, today announced certification for its intraocular lens (IOL) portfolio under the European Medical Device Regulation (MDR, (EU) 2017/745) from its Notified Body, the British Standards Institution (BSI)¹. The new regulatory criteria came into effect in May 2021, replacing the prior Medical Device Directive (MDD). Read More
BVI Announces ECAT Contract Additions for Government Customers
Government customers can now purchase BVI’s high-quality ophthalmic products through Lovell Government Services’ ECAT Contract. Read More
BVI Announces Investment & Collaboration with Beyeonics Vision
Supports surgeon-centered digital visualization, improved ergonomics and real-timeguidance to surgical decision-making process Read More
BVI Innovates to Treat Eye Diseases
BVI transformed from producing surgical knives to treating eye diseases as a next-generation company. Here’s how the business is still innovating. Read More